4.8 Article

Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 125, Issue 7, Pages 2609-2625

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI78443

Keywords

-

Funding

  1. VA [1I01BX000566-01, 547771] Funding Source: Federal RePORTER
  2. NHLBI NIH HHS [R01 HL071797, HL-076167, R01 HL076167, HL-071797] Funding Source: Medline
  3. NIGMS NIH HHS [R01 GM082830] Funding Source: Medline
  4. NINDS NIH HHS [K08 NS078048, K08NS078048] Funding Source: Medline
  5. BLRD VA [I01 BX000566] Funding Source: Medline

Ask authors/readers for more resources

Subarachnoid hemorrhage (SAH) carries a 50% mortality rate. The extravasated erythrocytes that surround the brain contain heme, which, when released from damaged red blood cells, functions as a potent danger molecule that induces sterile tissue injury and organ dysfunction. Free heme is metabolized by heme oxygenase (HO), resulting in the generation of carbon monoxide (CO), a bioactive gas with potent immunomodulatory capabilities. Here, using a murine model of SAH, we demonstrated that expression of the inducible HO isoform (HO-1, encoded by Hmox1) in microglia is necessary to attenuate neuronal cell death, vasospasm, impaired cognitive function, and clearance of cerebral blood burden. Initiation of CO inhalation after SAH rescued the absence of microglial HO-land reduced injury by enhancing erythrophagocytosis. Evaluation of correlative human data revealed that patients with SAH have markedly higher HO-1 activity in cerebrospinal fluid (CSF) compared with that in patients with unruptured cerebral aneurysms. Furthermore, cisternal hematoma volume correlated with HO-1 activity and cytokine expression in the CSF of these patients. Collectively, we found that microglial HO-1 and the generation of CO are essential for effective elimination of blood and heme after SAH that otherwise leads to neuronal injury and cognitive dysfunction. Administration of CO may have potential as a therapeutic modality in patients with ruptured cerebral aneurysms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available